{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:14:15Z","timestamp":1791026055857,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","award":["MISTRZ 2009\u20132011"],"award-info":[{"award-number":["MISTRZ 2009\u20132011"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.pnpbp.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T08:50:21Z","timestamp":1311411021000},"page":"1870-1876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Andres-Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Barcicka-Klosowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Florek-Luszczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Haratym-Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.07.001_bb0005","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1360-0443.1996.911115852.x","article-title":"Cannabis: pharmacology and toxicology in animals and humans","volume":"91","author":"Adams","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2009.01.003","article-title":"Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB 1 agonist ACEA in the pentylenetetrazole-induced seizure in mice","volume":"84","author":"Bahremand","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle methode simple pour explorer l'action tranquilisante: le test de la cheminee","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp (Basel)"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0020","series-title":"Epilepsy","article-title":"Fast facts","author":"Brodie","year":"2001"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0025","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM200104123441507","article-title":"Epilepsy","volume":"344","author":"Browne","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0006-2952(96)00419-4","article-title":"Role of cyclic AMP in the actions of cannabinoid receptors","volume":"52","author":"Childers","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1528-1157.1979.tb04816.x","article-title":"The influence of cannabinoid and delta-9-tetrahydrocannabinol on cobalt epilepsy in rats","volume":"20","author":"Chiu","year":"1979","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)30824-4","article-title":"Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats","volume":"201","author":"Consroe","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-3565(25)09495-9","article-title":"Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process","volume":"273","author":"Deadwyler","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0050","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.seizure.2009.06.009","article-title":"Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model","volume":"18","author":"Dudra-Jastrzebska","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2009.01.036","article-title":"Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus","volume":"1262","author":"Falenski","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuropharm.2007.08.005","article-title":"Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice","volume":"53","author":"Gholizadeh","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0075","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1211\/0022357011777891","article-title":"Protective effects of cannabinoid receptor agonist against cocaine and other convulsant-induced toxic behavioural symptoms","volume":"53","author":"Hayase","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(95)11289-9","article-title":"Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes","volume":"186","author":"Henry","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.pa.35.040195.003135","article-title":"Pharmacology of cannabinoid receptors","volume":"35","author":"Howlett","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2011.07.001_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1469-7793.2001.0731e.x","article-title":"Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons","volume":"532","author":"Huang","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0105","first-page":"108","article-title":"Interactions between antiepileptic drugs and herbal medicines","volume":"7","author":"Johannessen-Landmark","year":"2008","journal-title":"Bol Latinoam Caribe Plant Med Aromaticas"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0110","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0024-3205(73)90141-0","article-title":"The anticonvulsant activity of cannabidiol and cannabiol","volume":"13","author":"Karler","year":"1973","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0024-3205(74)90009-5","article-title":"Anticonvulsant properties of delta-9-tetrahydrocannabinol and other cannabinoids","volume":"15","author":"Karler","year":"1974","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2220\/biomedres.26.241","article-title":"Cannabinoid suppressed bicuculline-induced convulsion without respiratory depression in the brainstem-spinal cord preparation from newborn rats","volume":"26","author":"Koda","year":"2005","journal-title":"Biomed Res"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0125","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0022-3565(25)10152-3","article-title":"Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids","volume":"264","author":"Kuster","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails: substitution or add-on?","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-6147(00)01974-X","article-title":"Current status and current directions in the pharmacotherapy of epilepsy","volume":"23","author":"L\u00f6scher","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2008.11.049","article-title":"Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"602","author":"Luszczki","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00702-008-0046-3","article-title":"Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model","volume":"115","author":"Luszczki","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pbb.2011.01.002","article-title":"Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"98","author":"Luszczki","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0170","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","article-title":"Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"30","author":"Luszczki","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eplepsyres.2009.03.027","article-title":"Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study","volume":"85","author":"Luszczki","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0180","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.89.9.3825","article-title":"Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells","volume":"89","author":"Mackie","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0185","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995","article-title":"Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor","volume":"15","author":"Mackie","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0009-3084(02)00144-5","article-title":"Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects","volume":"121","author":"Mechoulam","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0200","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav Toxicol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0205","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00702-008-0076-x","article-title":"Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice","volume":"115","author":"Naderi","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1528-1157.1993.tb02126.x","article-title":"Some aspects of prognosis in the epilepsies: a review","volume":"34","author":"Sander","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0220","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-8993(97)01195-5","article-title":"The cannabinoid agonist WIN 55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons","volume":"783","author":"Shen","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(24)23149-7","article-title":"Delta-9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture","volume":"55","author":"Shen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/jn.1997.78.1.43","article-title":"Cannabinoids inhibit N- and P\/Q-type calcium channels in cultured rat hippocampal neurons","volume":"78","author":"Twitchell","year":"1997","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0245","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1528-1167.2009.02510.x","article-title":"WAG\/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges","volume":"51","author":"van Rijn","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0250","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoid in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.07.001_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur J Pharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:41:53Z","timestamp":1759520513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0278584611002181"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.07.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}